This year, nearly 150,000 Australians will be diagnosed with cancer and 50,000 will succumb to the disease.

We are at a pivotal time when innovations in biology, technology and data science offer new hope for cancer outcomes.

Ovarian cancer hope

“We have developed a novel antibody targeting leader cells and are now advancing towards first in-human clinical trials to bring new hope to women with ovarian cancer. By targeting these cells, we aim to develop new therapies to reduce metastasis, enhance immune responses, and improve outcomes for ovarian cancer patients.” – Dr Maree Bilandzic